Verrica Pharmaceuticals Inc (VRCA)
1.31
-0.14
(-9.66%)
USD |
NASDAQ |
Oct 04, 16:00
1.31
0.00 (0.00%)
Pre-Market: 20:00
Verrica Pharmaceuticals Shareholders Equity (Annual): 19.76M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.76M |
| December 31, 2022 | 40.03M |
| December 31, 2021 | 32.60M |
| December 31, 2020 | 32.99M |
| Date | Value |
|---|---|
| December 31, 2019 | 65.02M |
| December 31, 2018 | 89.43M |
| December 31, 2017 | -7.041M |
| December 31, 2016 | -2.664M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
19.76M
Minimum
2023
65.02M
Maximum
2019
38.08M
Average
32.99M
Median
2020
Shareholders Equity (Annual) Benchmarks
| Biomarin Pharmaceutical Inc | 4.952B |
| Eagle Pharmaceuticals Inc | -- |
| Zevra Therapeutics Inc | 61.86M |
| scPharmaceuticals Inc | 37.22M |
| Terns Pharmaceuticals Inc | 255.37M |